List of SBIR/STTR awards granted to Q-State Biosciences
Q-State BiosciencesName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Q-State Biosciences in February, 2020 for $236,911.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS115350-01 | Phase I | 236,911 | February 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Q-State Biosciences in May, 2019 for $777,880.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44MH112273-03 | Phase II | 777,880 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in September, 2019 for $343,037.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43MH122924-01 | Phase I | 343,037 | September 13, 2019 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in September, 2019 for $450,292.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43MH122052-01 | Phase I | 450,292 | September 20, 2019 | |||||||
A SBIR Phase II contract was awarded to Q-State Biosciences in July, 2022 for $1,296,058.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44MH122052-03 | Phase II | 1,296,058 | July 19, 2022 | |||||||
A SBIR Phase II contract was awarded to Q-State Biosciences in September, 2022 for $1,500,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 9R44NS125689-04 | Phase II | 1,500,000 | September 15, 2022 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in May, 2018 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA224563-01A1 | Phase I | 299,999 | May 22, 2018 | |||||||
A SBIR Phase II contract was awarded to Q-State Biosciences in June, 2019 for $1,364,122.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44MH112474-05A1 | Phase II | 1,364,122 | June 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in September, 2020 for $451,550.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS117263-01A1 | Phase I | 451,550 | September 30, 2020 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in August, 2019 for $585,093.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44MH121169-01 | Phase I | 585,093 | August 8, 2019 | |||||||
A SBIR Phase II contract was awarded to Q-State Biosciences in July, 2019 for $731,940.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44NS107041-02 | Phase II | 731,940 | July 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in July, 2018 for $222,370.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44NS107041-01 | Phase I | 222,370 | July 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Q-State Biosciences in August, 2022 for $995,203.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44MH121169-02 | Phase II | 995,203 | August 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in January, 2017 for $764,645.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH112273-01 | Phase I | 764,645 | January 12, 2017 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in August, 2017 for $727,043.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH114781-01 | Phase I | 727,043 | August 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in September, 2017 for $896,097.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH113447-01A1 | Phase I | 896,097 | September 21, 2017 | |||||||
A SBIR Phase II contract was awarded to Q-State Biosciences in September, 2016 for $994,649.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44MH112474-03 | Phase II | 994,649 | September 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in April, 2016 for $824,331.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL126314-01 | Phase I | 824,331 | April 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Q-State Biosciences in April, 2016 for $972,225.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL126314-02A1 | Phase II | 972,225 | April 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Q-State Biosciences in April, 2014 for $678,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS087714-01 | Phase I | 678,000 | April 1, 2014 |
